Related Experiment Video
Updated: May 9, 2026
06:35
An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
Genetic component of giant cell arteritis
F David Carmona1, Miguel A González-Gay, Javier Martín
1Instituto de Parasitología y Biomedicina López-Neyra, Consejo Superior de Investigaciones Científicas, Parque Tecnológico Ciencias de la Salud, Avenida del Conocimiento s/n, 18100-Armilla, Granada, Spain. martin@ipb.csic.es.
Rheumatology (Oxford, England)
|July 12, 2013
Summary
Giant cell arteritis (GCA) genetics are increasingly understood, with key immune response genes identified. This review summarizes current knowledge on genetic factors influencing GCA predisposition and severity.
Area of Science:
- Immunology
- Genetics
- Rheumatology
Background:
- Autoimmune diseases have a significant genetic component, but mechanisms for rarer conditions like GCA remain unclear.
- Giant cell arteritis (GCA) is an antigen-driven systemic vasculitis affecting elderly individuals.
- Previous genetic studies on GCA, though sometimes limited, have implicated the MHC region and immune response genes.
Purpose of the Study:
- To review and summarize the current understanding of the genetic factors contributing to GCA predisposition and severity.
- To consolidate findings from various genetic studies on GCA.
- To highlight the need for further research into the molecular mechanisms of GCA.
Main Methods:
- Literature review of genetic studies on GCA.
- Analysis of identified genetic associations.
- Synthesis of current knowledge on GCA genetics.
Main Results:
- Genetic studies consistently point to genes within the MHC region, particularly HLA-DRB1*04 alleles, as significant in GCA.
- Other immune and inflammatory response genes (cytokines, adhesion molecules, innate immunity regulators) are implicated in GCA development.
- The genetic architecture of GCA involves multiple contributing factors.
Conclusions:
- Significant progress has been made in understanding the genetic basis of GCA.
- Key genetic players in GCA include HLA-DRB1*04 and other immune-related genes.
- Further research is needed to elucidate the precise molecular mechanisms underlying GCA pathogenesis.
Related Concept Videos
01:11Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
01:29Autoimmune Disorders
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Concept and Mechanism of Autoimmune Diseases
The immune system...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
02:32Exon Recombination
The evolution of new genes is critical for speciation. Exon recombination, also known as exon shuffling or domain shuffling, is an important means of new gene formation. It is observed across vertebrates, invertebrates, and in some plants such as potatoes and sunflowers. During exon recombination, exons from the same or different genes recombine and produce new exon-intron combinations, which might evolve into new genes.
Exon shuffling follows “splice frame rules.” Each exon has three reading...
Exon shuffling follows “splice frame rules.” Each exon has three reading...